Correlation of spirometry indices to chest radiology in the diagnosis of chronic airway disease among regional and rural Indigenous Australians.


Journal

Internal medicine journal
ISSN: 1445-5994
Titre abrégé: Intern Med J
Pays: Australia
ID NLM: 101092952

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 18 09 2022
accepted: 15 01 2023
medline: 27 11 2023
pubmed: 31 1 2023
entrez: 30 1 2023
Statut: ppublish

Résumé

The majority of Indigenous Australians reside in non-urban locations, with reduced access to chest radiology such as computed tomography (CT). Spirometry and chest X-ray (CXR) may be used in the absence of CT; however, the correlation of spirometry indices to CT-defined chronic airway diseases (i.e. chronic obstructive pulmonary disease (COPD) and bronchiectasis) compared with CXR among Indigenous people is sparsely reported. To evaluate spirometry indices against CXR and CT findings among adult Indigenous Australians. Indigenous patients who had undergone a spirometry test between 2012 and 2020 and had a CXR or chest CT scan assessed for the presence ( Of 643 patients (57% female, 31% remote/very remote), 364 (57%) had CT and CXR available. Patients who were 'CT Indigenous Australians tend to demonstrate restrictive impairment in the absence of radiological evidence of airway disease. However, in the presence of airway disease, combinations of mixed and obstructive impairments were common. Obstructive impairment shows greater sensitivity for identifying COPD than that shown by CXR; however, CXR shows greater specificity. Hence, spirometry in conjunction with chest radiology should be utilised to aid in the assessment of airway diseases in this population.

Sections du résumé

BACKGROUND BACKGROUND
The majority of Indigenous Australians reside in non-urban locations, with reduced access to chest radiology such as computed tomography (CT). Spirometry and chest X-ray (CXR) may be used in the absence of CT; however, the correlation of spirometry indices to CT-defined chronic airway diseases (i.e. chronic obstructive pulmonary disease (COPD) and bronchiectasis) compared with CXR among Indigenous people is sparsely reported.
AIM OBJECTIVE
To evaluate spirometry indices against CXR and CT findings among adult Indigenous Australians.
METHODS METHODS
Indigenous patients who had undergone a spirometry test between 2012 and 2020 and had a CXR or chest CT scan assessed for the presence (
RESULTS RESULTS
Of 643 patients (57% female, 31% remote/very remote), 364 (57%) had CT and CXR available. Patients who were 'CT
CONCLUSION CONCLUSIONS
Indigenous Australians tend to demonstrate restrictive impairment in the absence of radiological evidence of airway disease. However, in the presence of airway disease, combinations of mixed and obstructive impairments were common. Obstructive impairment shows greater sensitivity for identifying COPD than that shown by CXR; however, CXR shows greater specificity. Hence, spirometry in conjunction with chest radiology should be utilised to aid in the assessment of airway diseases in this population.

Identifiants

pubmed: 36710443
doi: 10.1111/imj.16023
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1994-2006

Informations de copyright

© 2023 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians.

Références

Soriano JB, Kendrick PJ, Paulson KR, Gupta V, Abrams EM, Adedoyin RA et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med 2017; 8: 585-96.
Ospina MB, Voaklander DC, Stickland MK, King M, Senthilselvan A, Rowe BH. Prevalence of asthma and chronic obstructive pulmonary disease in Aboriginal and non-Aboriginal populations: a systematic review and meta-analysis of epidemiological studies. Can Respir J 2012; 19: 355-60.
Kruavit A, Fox M, Pearson R, Heraganahally S. Chronic respiratory disease in the regional and remote population of the Northern Territory Top End: a perspective from the specialist respiratory outreach service. Aust J Rural Health 2017; 25: 275-84.
Heraganahally SS, Wasgewatta SL, McNamara K, Eisemberg CC, Budd RC, Mehra S et al. Chronic obstructive pulmonary disease in aboriginal patients of the Northern Territory of Australia: a landscape perspective. Int J Chron Obstruct Pulmon Dis 2019; 14: 2205-17.
Heraganahally SS, Wasgewatta SL, McNamara K, Mingi JJ, Mehra S, Eisemberg CC et al. Chronic obstructive pulmonary disease with and without bronchiectasis in Aboriginal Australians - a comparative study. Intern Med J 2020; 50: 1505-13.
Mehra S, Chang AB, Lam CK, Campbell S, Mingi JJ, Thomas I et al. Bronchiectasis among Australian Aboriginal and non-Aboriginal patients in the regional and remote population of the Northern Territory of Australia. Rural Remote Health 2021; 21: 6390.
Heraganahally SS, Timothy TP, Sorger L. Chest computed tomography findings among adult indigenous Australians in the Northern Territory of Australia. J Med Imaging Radiat Oncol 2022; 66: 337-44.
Heraganahally SS, Ghimire RM, Howarth T, Kankanamalage OM, Palmer D, Falhammar H. Comparison and outcomes of emergency department presentations with respiratory disorders among Australian indigenous and non-indigenous patients. BMC Emerg Med 2022; 22: 11.
Australian Bureau of Statistics. Estimates of Aboriginal and Torres Strait Islander Australians. Canberra: The Bureau; 2016.
State of the World's Indigenous Peoples. Indigenous Peoples' access to Health Services. United Nations. 2018 [cited 2022 Aug]. Available from URL: https://www.un.org/development/desa/indigenouspeoples/wp-content/uploads/sites/19/2018/03/The-State-of-The-Worlds-Indigenous-Peoples-WEB.pdf
Raoof S, Feigin D, Sung A, Raoof S, Irugulpati L, Rosenow EC III. Interpretation of plain chest roentgenogram. Chest 2012; 141: 545-58.
Raju S, Ghosh S, Mehta AC. Chest CT signs in pulmonary disease: A pictorial review. Chest 2017; 151: 1356-74.
Johnson JD, Theurer WH. A stepwise approach to the interpretation of pulmonary function tests. Am Fam Physician 2014; 89: 359-66.
Mostafa MMS. Role of the chest radiography, spirometry, and high resolution computed tomography in the early diagnosis of the emphysema. Egypt J Radiol Nucl Med 2010; 41: 509-15.
Singh A, Kumar S, Mishra AK, Kumar M, Kant S, Verma SK et al. Correlation between clinical characteristics, spirometric indices and high resolution computed tomography findings in patients of chronic obstructive pulmonary disease. Lung India 2016; 33: 42-8.
Chen H, Chen RC, Guan YB, Li W, Liu Q, Zeng QS. Correlation of pulmonary function indexes determined by low-dose MDCT with spirometric pulmonary function tests in patients with chronic obstructive pulmonary disease. AJR Am J Roentgenol 2014; 202: 711-8.
Schubert J, Kruavit A, Mehra S, Wasgewatta S, Chang AB, Heraganahally SS. Prevalence and nature of lung function abnormalities among indigenous Australians referred to specialist respiratory outreach clinics in the Northern Territory. Intern Med J 2019; 49: 217-24.
Heraganahally SS, Howarth T, White E, Sorger L, Biancardi E, Ben SH. Lung function parameters among “apparently healthy” Australian Aboriginal adults: an Australian Caucasian and Global Lung Initiative (GLI-2012) various ethnic norms comparative study. Expert Rev Respir Med 2020; 23: 1-11.
Heraganahally SS, Howarth T, Mo L, Sorger L, Ben SH. Critical analysis of spirometric patterns in correlation to chest computed tomography among adult indigenous Australians with chronic airway diseases. Expert Rev Respir Med 2021; 15: 1229-38.
National Health and Medical Research Council. Ethical Conduct in Research with Aboriginal and Torres Strait Islander Peoples and Communities: Guidelines for Researchers and Stakeholders. Canberra: Commonwealth of Australia; 2018.
Australian Bureau of Statistics. Australian Statistical Geography Standard (ASGS): Volume 5-Remoteness Structure, July 2011. ABS cat. no. 1270.0.55.005. Canberra: The Bureau.
Pipavath SNJ, Schmidt RA, Takasugi JE, Godwin JD. Chronic obstructive pulmonary disease: radiology-pathology correlation. J Thorac Imaging 2009; 24: 171-80.
Gaillard F, Weerakkody Y. Bronchiectasis. Reference article, Radiopaedia.org [cited 2022 Aug 1]. Available from URL: https://doi.org/10.53347/rID-1021
ndd Medical Technologies, 2017. EasyOne Pro® [cited 2022 Aug]. Available from URL: https://www.ndd.ch/en/product/easyone-pro.html
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A. Standardisation of spirometry. “ATS/ERS task force: standardisation of lung function testing”. Eur Respir J 2005; 26: 319-38.
Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999; 159: 179-87.
Guezguez F, Knaz H, Anane I, Bougrida M, Ben SH. The ‘clinically significant’ bronchodilator responsiveness (BDR) in children: a comparative study between six definitions of scholarly societies and a mini-review. Expert Rev Respir Med 2021; 15: 823-32.
Stanojevic S, Kaminsky DA, Miller MR, Thompson B, Aliverti A, Barjakteravic I et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J 2021; 23: 2101499.
Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease [cited 2022 Aug]. Available from URL: http://www.goldcopd.org
Blake TL, Chang AB, Petsky HL, Rodwell LT, Brown MG, Hill DC et al. Spirometry reference values in indigenous Australians: a systematic review. Med J Aust 2016; 205: 35-40.
Veale A, Peat J, Salome C, Woolcock AJ, Thompson JE. Normal lung function in rural Australian Aborigines. Aust N Z J Med 1997; 27: 543-9.
Cooksley NA, Atkinson D, Marks GB, Toelle BG, Reeve D, Johns DP et al. Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population: the cross-sectional BOLD study. Respirology 2015; 20: 766-74.
Ray E, Culliford D, Kruk H, Gillett K, North M, Astles CM et al. Specialist respiratory outreach: a case-finding initiative for identifying undiagnosed COPD in primary care. NPJ Prim Care Respir Med 2021; 31: 7.
de São José BP, Camargos PA, Bateman ED, Botelho CMA, de Seixas Maciel JGF, Mancuzo EV et al. Primary care physicians' ability to diagnose the most prevalent respiratory diseases. Int J Tuberc Lung Dis 2016; 20: 1392-8.
Partridge MR. Enhancing the diagnosis and management of COPD in primary care. Multidiscip Respir Med 2014; 9: 62.
Steinfort DP, Brady S, Weisinger HS, Einsiedel L. Bronchiectasis in Central Australia: a young face to an old disease. Respir Med 2008; 102: 574-8.
Kurth L, Hnizdo E. Change in prevalence of restrictive lung impairment in the U.S. population and associated risk factors: the National Health and Nutrition Examination Survey (NHANES) 1988-1994 and 2007-2010. Multidiscip Respir Med 2015; 10: 7.
Australian Institute of Health and Welfare 2020. Australia's Children [cited 2022 Nov]. Available from URL: https://www.aihw.gov.au/reports/children-youth/australias-children/contents/health/birthweight
Chang AB, Brown N, Toombs M, Marsh RL, Redding GJ. Lung disease in indigenous children. Paediatr Respir Rev 2014; 15: 325-32.
Saad HB. Why a large percentage of Tunisian women aged 40 years and more has a reduced forced vital capacity? The implication of parity. BMC Pulm Med 2022; 22: 413.
Triki L, Ben SH. The impacts of parity on spirometric parameters: a systematic review. Expert Rev Respir Med 2021; 15: 1169-85.
Quanjer PH. Lung function, genetics and socioeconomic conditions. Eur Respir J 2015; 45: 1529-33.
Vimala LR, Gibikote S, Christopher DJ, Irodi A, Rajan M, Ramasami P. Correlation of digital chest radiograph parameters with pulmonary function test and BODE index for diagnosis and prognostication in Indian COPD patients. J Lung Pulm Resp Res 2018; 5: 00154.
Tseng HJ, Henry TS, Veeraraghavan S, Mittal PK, Little BP. Pulmonary function tests for the radiologist. Radiographics 2017; 37: 1037-58.
Heraganahally SS, Silva SA, Howarth TP, Kangaharan N, Majoni S. Comparison of clinical manifestation among Australian indigenous and non- indigenous patients presenting with pleural effusion. Intern Med J 2022; 52: 1232-41.
Pal A, Howarth TP, Rissel C, Messenger R, Isaac S, Ford L et al. COPD disease knowledge, self-awareness and reasons for hospital presentations among a predominately indigenous Australian cohort - a study to explore preventable hospitalization. BMJ Open Respir Res 2022; 9: e001295.
Heraganahally SS, Howarth TP, Lloyd A, White E, Veale A, Ben SH. The prevalence of bronchodilator responsiveness “asthma” among adult indigenous Australians referred for lung function testing in the Top End Northern Territory of Australia. J Asthma Allergy 2022; 15: 1305-19.

Auteurs

Timothy Howarth (T)

College of Health and Human Sciences, Charles Darwin University, Darwin, Northern Territory, Australia.
Darwin Respiratory and Sleep Health, Darwin Private Hospital, Darwin, Northern Territory, Australia.
Department of Technical Physics, University of Eastern Finland, Kuopio, Finland.

Daniel Gahreman (D)

College of Health and Human Sciences, Charles Darwin University, Darwin, Northern Territory, Australia.
Department of Sport, Exercise, Recreation, and Kinesiology, East Tennessee State University, Johnson City, Tennessee, USA.

Helmi Ben Saad (H)

Faculté de Médecine de Sousse, Hôpital Farhat HACHED de Sousse, Laboratoire de recherche 'Insuffisance Cardiaque' (LR12SP09), Université de Sousse, Sousse, Tunisia.

Lai Ng (L)

Department of Respiratory and Sleep Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia.

Subash S Heraganahally (SS)

Darwin Respiratory and Sleep Health, Darwin Private Hospital, Darwin, Northern Territory, Australia.
Department of Respiratory and Sleep Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH